First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21293199

AIDS 2011 Feb 20 25 4 479-92

Download in:

View as

General Info

PMID
21293199